의료용 비즈니스 인텔리전스 시장 규모, 점유율, 업계 분석 : 컴포넌트별, 제공 모드별, 애플리케이션별, 최종 용도별, 지역별, 전망과 예측(2026-2033년)

The Global Healthcare Business Intelligence Market is expected to reach USD 30.7 billion by 2033, growing at a CAGR of 13.8% during (2026 - 2033).

Healthcare business intelligence market is driven by the rising need for operational efficiency, data-driven decision making, revenue cycle optimization, enhanced patient outcomes, population health management, clinical performance tracking, and regulatory compliance. The market demand is also rising as clinics, hospitals, healthcare manufacturers, and pharmaceutical companies adopt dashboards, analytics platforms, predictive analytics, interoperable data systems, and cloud-based business intelligence. The market evolved from the need to convert large healthcare datasets into actionable insights across financial, clinical, and operational functions.

• By component, Software dominated the market in 2025 with USD 7.5 billion and is expected to reach USD 20.5 billion by 2033, growing at a CAGR of 13.6%.
• Services is expected to grow faster by component, registering a CAGR of 14.2% during (2026 - 2033), supported by consulting, implementation, integration, training, managed services, and BI optimization needs.
• By mode of delivery, Cloud-based dominated the market in 2025 with USD 5.1 billion and is expected to reach USD 13.7 billion by 2033, growing at a CAGR of 13.2%.
• Hybrid is expected to grow fastest by mode of delivery, registering a CAGR of 14.4% during (2026 - 2033), supported by flexible deployment, data security needs, cloud scalability, and on-premise control.
• By application, Financial Analysis dominated the market in 2025 with USD 3.8 billion and is expected to reach USD 10.1 billion by 2033, growing at a CAGR of 13.0%.
• Operational Analysis and Patient Care are expected to grow fastest by application, each registering a CAGR of 14.4% during (2026 - 2033), supported by workflow optimization, resource planning, personalized care, and outcome-based healthcare.
• By end use, Payers dominated the market in 2025 with USD 5.3 billion and is expected to reach USD 14.1 billion by 2033, while Healthcare Manufacturers are expected to grow fastest with a CAGR of 14.5%.
• Regionally, North America dominated the market in 2025 with USD 5.1 billion and is projected to reach USD 13.8 billion by 2033, while LAMEA is expected to grow fastest with a CAGR of 15.2% during (2026 - 2033).

Healthcare business intelligence market is rising as healthcare enterprises shift from fragmented toward AI-enabled, unified, and real-time platforms, Business intelligence are largely used to combine data from imaging systems, administrative workflows, EHRs, and payer portals. The market benefits from the growing demand for compliance-ready reporting, predictive insights, cloud-native data ecosystems, patient-centered analytics, and workflow optimization.

Competitive landscape of market is healthcare data-driven, supported by healthcare specialized analytics companies, enterprise business intelligence vendors, cloud-based visualization providers, and HER-integrated intelligence platforms. Market players are positioning themselves ahead through clinical workflow alignment, real-time reporting, healthcare data integration, clinical workflow alignment, scalable cloud deployment, and self-service dashboards. Market competition is predicted to depend on predictive modeling, interoperability, embedded analytics, and the capability to convert segmented healthcare data into actionable intelligence.

Drivers

• Increasing Demand for Advanced Data Analytics to Enhance Healthcare Outcomes
• Regulatory Compliance and Data Governance Requirements Fueling BI Adoption
• Integration of Artificial Intelligence to Drive Operational Efficiency and Insight Generation
• Strategic Emphasis on Data-Driven Decision Making within Healthcare Organizations

Restraints

• Data Privacy and Regulatory Compliance Challenges
• High Implementation and Operational Costs
• Data Quality and Integration Limitations

Opportunities

• Expansion of AI-Driven Clinical Decision Support Systems within Healthcare Business Intelligence
• Leveraging Digital Transformation Initiatives Fuelled by Regulatory and Funding Support
• Addressing Legal and Ethical Challenges to Build Trust in AI-Powered Healthcare Analytics

Challenges

• Data Privacy and Security Concerns in Healthcare Business Intelligence Market
• High Costs and Resource Intensity of Healthcare Business Intelligence Deployment
• Data Integration and Interoperability Challenges in Healthcare Business Intelligence

Market Share Analysis

Healthcare business intelligence market represents a dynamic competitive landscape driven by healthcare-specialized business intelligence companies, broad enterprise analytics vendors, cloud-based visualization providers, and EHR-integrated platforms. Salesforce, Oracle Corporation, Microsoft Corporation hold strong positions through cloud infrastructure, enterprise analytics, interactive dashboard capabilities, and healthcare data platforms. SAP, SAS, Innovaccer, Health Catalyst, QlikTech, Epic, and Infor further strengthen competition through payer intelligence, clinical analytics, embedded reporting, population health management, embedded reporting, and healthcare-specific data integration.

Component Outlook

Based on Component, the market is segmented into Software and Services. The Software market dominated the Global Healthcare Business Intelligence Market by Component in 2025, and would continue to be a dominant market till 2033; thereby, achieving a market value of USD 20.5 billion by 2033, growing at a CAGR of 13.6 % during the forecast period. The Services market is expected to witness a CAGR of 14.2% during (2026 - 2033).

Software leads the market as healthcare organizations rely on analytics platforms, data visualization tools, predictive modeling, AI-enabled decision support, and reporting systems. Services support consulting, implementation, integration, training, managed analytics, and ongoing optimization. Both segments are essential as healthcare organizations require strong BI technology along with expert support to manage complex data environments.

Mode of Delivery Outlook

Based on Mode of Delivery, the market is segmented into Cloud-based, On-premise, and Hybrid. The Cloud-based market dominated the Global Healthcare Business Intelligence Market by Mode of Delivery in 2025, and would continue to be a dominant market till 2033; thereby, achieving a market value of USD 13.7 billion by 2033, growing at a CAGR of 13.2 % during the forecast period. The On-premise market is expected to witness a CAGR of 14.2% during (2026 - 2033). The Hybrid market is expected to witness a CAGR of 14.4% during (2026 - 2033).

Cloud-based deployment leads due to scalability, remote access, lower infrastructure burden, and easier integration with digital healthcare platforms. On-premise remains important for organizations requiring direct control over sensitive patient data and customized IT environments. Hybrid deployment is gaining adoption by combining on-premise security with cloud flexibility and analytics scalability.

Application Outlook

Based on Application, the market is segmented into Financial Analysis, Clinical Analysis, Operational Analysis, and Patient Care. The Financial Analysis market dominated the Global Healthcare Business Intelligence Market by Application in 2025, and would continue to be a dominant market till 2033; thereby, achieving a market value of USD 10.1 billion by 2033, growing at a CAGR of 13 % during the forecast period. The Clinical Analysis market is expected to witness a CAGR of 14% during (2026 - 2033). Additionally, The Operational Analysis market is expected to witness highest CAGR of 14.4% during (2026 - 2033).

Financial Analysis leads as healthcare organizations focus on revenue cycle management, cost control, claims review, and financial performance monitoring. Clinical Analysis supports evidence-based care, treatment outcome tracking, and decision support. Operational Analysis improves workflow efficiency and resource use, while Patient Care supports engagement, personalized care, and outcome-based management.

End Use Outlook

Based on End Use, the market is segmented into Payers, Healthcare Providers, and Healthcare Manufacturers. The Payers market dominated the Global Healthcare Business Intelligence Market by End Use in 2025, and would continue to be a dominant market till 2033; thereby, achieving a market value of USD 14.1 billion by 2033, growing at a CAGR of 13.2 % during the forecast period. The Healthcare Providers market is expected to witness a CAGR of 14.2% during (2026 - 2033).

Payers led the market through extensive use of BI for claims management, fraud detection, risk assessment, reimbursement optimization, and cost containment. Healthcare Providers use BI to improve clinical quality, operational efficiency, patient outcomes, and regulatory reporting. Healthcare Manufacturers adopt BI for supply chain optimization, product performance analysis, regulatory compliance, and market intelligence.

Regional Outlook

Region-wise, the Healthcare Business Intelligence Market is analyzed across North America, Europe, Asia Pacific, and LAMEA.

In 2025, the North America region held the largest share in the healthcare business intelligence market, by achieving a market share of USD 13.8 billion with a CAGR of 13.8% by 2033. The APAC region is predicted to grow at a CAGR of 14.5% during the forecast period. Moreover, the Europe region is anticipated to expand at a CAGR of 13.6% during 2026-2033.

North America market is supported by strong digital health adoption, advanced healthcare IT infrastructure, and high investment in data-driven healthcare decision making. Europe region is driven by healthcare digitization, electronic health record adoption, and strict regulatory needs. Asia Pacific is witnessing expansion cloud analytics adoption, healthcare infrastructure growth. Furthermore, LAMEA region is developing through enhancing digital infrastructure and healthcare modernization.

Recent Strategies Deployed in the Market

• 2025-September: Oracle launched the Oracle AI Center of Excellence for Healthcare in the United States to help healthcare organizations accelerate AI adoption across clinical, operational, and financial workflows.
• 2025-October: Qlik introduced Qlik Predict in the United States, a no-code predictive analytics solution that enables healthcare users to build and operationalize machine learning models without advanced data science expertise.
• 2025-August: Oracle launched its next-generation AI-driven Electronic Health Record platform in the United States, integrating embedded AI agents, conversational search, voice-enabled documentation, contextual clinical intelligence, and workflow automation.
• 2025-September: Baystate Health expanded its strategic collaboration with Oracle Health in the United States to establish an AI Innovation Lab focused on healthcare delivery, operational management, patient engagement, and enterprise decision-making.
• 2025-September: Oracle expanded its global healthcare AI services through the AI Center of Excellence, offering healthcare providers AI governance, technical consulting, implementation guidance, and enterprise deployment support.

List of Key Companies Profiled

• Microsoft Corporation
• Oracle Corporation
• Salesforce, Inc.
• Health Catalyst, Inc.
• QlikTech International AB
• Innovaccer Inc.
• SAP SE
• SAS Institute Inc.
• Infor, Inc.
• Epic Systems Corporation

Global Healthcare Business Intelligence Market Report Segmentation

By Component

• Software
• Services

By Mode of Delivery

• Cloud-based
• On-premise
• Hybrid

By Application

• Financial Analysis
• Clinical Analysis
• Operational Analysis
• Patient Care

By End Use

• Payers
• Healthcare Providers
• Healthcare Manufacturers

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1. Research Scope & Methodology

• 1.1 Market Definition
• 1.2 Analysis Period & Currency
• 1.3 Segmentation
• 1.4 Healthcare Business Intelligence Market, by Geography
• 1.5 Research Methodology

Chapter 2. Market Overview

• 2.1 COVID-19 Impact
• 2.2 Market Composition and Scenario

Chapter 3. Key Factors Impacting Market

• 3.1 Market Drivers
• 3.2 Market Restraints
• 3.3 Market Opportunities
• 3.4 Market Challenges
• 3.5 Market Trends
• 3.6 State of Competition
• 3.7 Market Consolidation
• 3.8 Key Customer Criteria

Chapter 4. Product Life Cycle

Chapter 5. Value Chain Analysis of Healthcare Business Intelligence Market

Chapter 6. Competition Analysis - Global

• 6.1 Market Share Analysis
• 6.2 Recent Developments
  • 6.2.1 Product Launch & Product Expansion
  • 6.2.2 Partnership, Collaboration & Agreements
  • 6.2.3 Geographical Expansion

Chapter 7. Segmentation By Component

• 7.1 Software
• 7.2 Services

Chapter 8. Segmentation By Mode of Delivery

• 8.1 Cloud-based
• 8.2 On-premise
• 8.3 Hybrid

Chapter 9. Segmentation By Application

• 9.1 Financial Analysis
• 9.2 Clinical Analysis
• 9.3 Operational Analysis
• 9.4 Patient Care

Chapter 10. Segmentation By End Use

• 10.1 Payers
• 10.2 Healthcare Providers
• 10.3 Healthcare Manufacturers

Chapter 11. North America Market

• 11.1 Market Overview
• 11.2 Key Factors Impacting Market
  • 11.2.1 Market Drivers
  • 11.2.2 Market Restraints
  • 11.2.3 Market Opportunities
  • 11.2.4 Market Challenges
  • 11.2.5 Market Trends
  • 11.2.6 State of Competition
  • 11.2.7 Market Consolidation
  • 11.2.8 Key Customer Criteria
• 11.3 Product Life Cycle
• 11.4 Segmentation By Component
  • 11.4.1 Software
  • 11.4.2 Services
• 11.5 Segmentation By Mode of Delivery
  • 11.5.1 Cloud-based
  • 11.5.2 On-premise
  • 11.5.3 Hybrid
• 11.6 Segmentation By Application
  • 11.6.1 Financial Analysis
  • 11.6.2 Clinical Analysis
  • 11.6.3 Operational Analysis
  • 11.6.4 Patient Care
• 11.7 Segmentation By End Use
  • 11.7.1 Payers
  • 11.7.2 Healthcare Providers
  • 11.7.3 Healthcare Manufacturers
• 11.8 Segmentation By Country
  • 11.8.1 US
    • 11.8.1.1 Segmentation By Component
      • 11.8.1.1.1 Software
      • 11.8.1.1.2 Services
    • 11.8.1.2 Segmentation By Mode of Delivery
      • 11.8.1.2.1 Cloud-based
      • 11.8.1.2.2 On-premise
      • 11.8.1.2.3 Hybrid
    • 11.8.1.3 Segmentation By Application
      • 11.8.1.3.1 Financial Analysis
      • 11.8.1.3.2 Clinical Analysis
      • 11.8.1.3.3 Operational Analysis
      • 11.8.1.3.4 Patient Care
    • 11.8.1.4 Segmentation By End Use
      • 11.8.1.4.1 Payers
      • 11.8.1.4.2 Healthcare Providers
      • 11.8.1.4.3 Healthcare Manufacturers
  • 11.8.2 Canada
    • 11.8.2.1 Segmentation By Component
      • 11.8.2.1.1 Software
      • 11.8.2.1.2 Services
    • 11.8.2.2 Segmentation By Mode of Delivery
      • 11.8.2.2.1 Cloud-based
      • 11.8.2.2.2 On-premise
      • 11.8.2.2.3 Hybrid
    • 11.8.2.3 Segmentation By Application
      • 11.8.2.3.1 Financial Analysis
      • 11.8.2.3.2 Clinical Analysis
      • 11.8.2.3.3 Operational Analysis
      • 11.8.2.3.4 Patient Care
    • 11.8.2.4 Segmentation By End Use
      • 11.8.2.4.1 Payers
      • 11.8.2.4.2 Healthcare Providers
      • 11.8.2.4.3 Healthcare Manufacturers
  • 11.8.3 Mexico
    • 11.8.3.1 Segmentation By Component
      • 11.8.3.1.1 Software
      • 11.8.3.1.2 Services
    • 11.8.3.2 Segmentation By Mode of Delivery
      • 11.8.3.2.1 Cloud-based
      • 11.8.3.2.2 On-premise
      • 11.8.3.2.3 Hybrid
    • 11.8.3.3 Segmentation By Application
      • 11.8.3.3.1 Financial Analysis
      • 11.8.3.3.2 Clinical Analysis
      • 11.8.3.3.3 Operational Analysis
      • 11.8.3.3.4 Patient Care
    • 11.8.3.4 Segmentation By End Use
      • 11.8.3.4.1 Payers
      • 11.8.3.4.2 Healthcare Providers
      • 11.8.3.4.3 Healthcare Manufacturers
  • 11.8.4 Rest of North America
    • 11.8.4.1 Segmentation By Component
      • 11.8.4.1.1 Software
      • 11.8.4.1.2 Services
    • 11.8.4.2 Segmentation By Mode of Delivery
      • 11.8.4.2.1 Cloud-based
      • 11.8.4.2.2 On-premise
      • 11.8.4.2.3 Hybrid
    • 11.8.4.3 Segmentation By Application
      • 11.8.4.3.1 Financial Analysis
      • 11.8.4.3.2 Clinical Analysis
      • 11.8.4.3.3 Operational Analysis
      • 11.8.4.3.4 Patient Care
    • 11.8.4.4 Segmentation By End Use
      • 11.8.4.4.1 Payers
      • 11.8.4.4.2 Healthcare Providers
      • 11.8.4.4.3 Healthcare Manufacturers

Chapter 12. Europe Market

• 12.1 Market Overview
• 12.2 Key Factors Impacting Market
  • 12.2.1 Market Drivers
  • 12.2.2 Market Restraints
  • 12.2.3 Market Opportunities
  • 12.2.4 Market Challenges
  • 12.2.5 Market Trends
  • 12.2.6 State of Competition
  • 12.2.7 Market Consolidation
  • 12.2.8 Key Customer Criteria
• 12.3 Product Life Cycle
• 12.4 Segmentation By Component
  • 12.4.1 Software
  • 12.4.2 Services
• 12.5 Segmentation By Mode of Delivery
  • 12.5.1 Cloud-Based
  • 12.5.2 On-Premise
  • 12.5.3 Hybrid
• 12.6 Segmentation By Application
  • 12.6.1 Financial Analysis
  • 12.6.2 Clinical Analysis
  • 12.6.3 Operational Analysis
  • 12.6.4 Patient Care
• 12.7 Segmentation By End Use
  • 12.7.1 Payers
  • 12.7.2 Healthcare Providers
  • 12.7.3 Healthcare Manufacturers
• 12.8 Segmentation By Country
  • 12.8.1 Germany
    • 12.8.1.1 Segmentation By Component
      • 12.8.1.1.1 Software
      • 12.8.1.1.2 Services
    • 12.8.1.2 Segmentation By Mode of Delivery
      • 12.8.1.2.1 Cloud-based
      • 12.8.1.2.2 On-premise
      • 12.8.1.2.3 Hybrid
    • 12.8.1.3 Segmentation By Application
      • 12.8.1.3.1 Financial Analysis
      • 12.8.1.3.2 Clinical Analysis
      • 12.8.1.3.3 Operational Analysis
      • 12.8.1.3.4 Patient Care
    • 12.8.1.4 Segmentation By End Use
      • 12.8.1.4.1 Payers
      • 12.8.1.4.2 Healthcare Providers
      • 12.8.1.4.3 Healthcare Manufacturers
  • 12.8.2 UK
    • 12.8.2.1 Segmentation By Component
      • 12.8.2.1.1 Software
      • 12.8.2.1.2 Services
    • 12.8.2.2 Segmentation By Mode of Delivery
      • 12.8.2.2.1 Cloud-based
      • 12.8.2.2.2 On-premise
      • 12.8.2.2.3 Hybrid
    • 12.8.2.3 Segmentation By Application
      • 12.8.2.3.1 Financial Analysis
      • 12.8.2.3.2 Clinical Analysis
      • 12.8.2.3.3 Operational Analysis
      • 12.8.2.3.4 Patient Care
    • 12.8.2.4 Segmentation By End Use
      • 12.8.2.4.1 Payers
      • 12.8.2.4.2 Healthcare Providers
      • 12.8.2.4.3 Healthcare Manufacturers
  • 12.8.3 France
    • 12.8.3.1 Segmentation By Component
      • 12.8.3.1.1 Software
      • 12.8.3.1.2 Services
    • 12.8.3.2 Segmentation By Mode of Delivery
      • 12.8.3.2.1 Cloud-based
      • 12.8.3.2.2 On-premise
      • 12.8.3.2.3 Hybrid
    • 12.8.3.3 Segmentation By Application
      • 12.8.3.3.1 Financial Analysis
      • 12.8.3.3.2 Clinical Analysis
      • 12.8.3.3.3 Operational Analysis
      • 12.8.3.3.4 Patient Care
    • 12.8.3.4 Segmentation By End Use
      • 12.8.3.4.1 Payers
      • 12.8.3.4.2 Healthcare Providers
      • 12.8.3.4.3 Healthcare Manufacturers
  • 12.8.4 Russia
    • 12.8.4.1 Segmentation By Component
      • 12.8.4.1.1 Software
      • 12.8.4.1.2 Services
    • 12.8.4.2 Segmentation By Mode of Delivery
      • 12.8.4.2.1 Cloud-based
      • 12.8.4.2.2 On-premise
      • 12.8.4.2.3 Hybrid
    • 12.8.4.3 Segmentation By Application
      • 12.8.4.3.1 Financial Analysis
      • 12.8.4.3.2 Clinical Analysis
      • 12.8.4.3.3 Operational Analysis
      • 12.8.4.3.4 Patient Care
    • 12.8.4.4 Segmentation By End Use
      • 12.8.4.4.1 Payers
      • 12.8.4.4.2 Healthcare Providers
      • 12.8.4.4.3 Healthcare Manufacturers
  • 12.8.5 Spain
    • 12.8.5.1 Segmentation By Component
      • 12.8.5.1.1 Software
      • 12.8.5.1.2 Services
    • 12.8.5.2 Segmentation By Mode of Delivery
      • 12.8.5.2.1 Cloud-based
      • 12.8.5.2.2 On-premise
      • 12.8.5.2.3 Hybrid
    • 12.8.5.3 Segmentation By Application
      • 12.8.5.3.1 Financial Analysis
      • 12.8.5.3.2 Clinical Analysis
      • 12.8.5.3.3 Operational Analysis
      • 12.8.5.3.4 Patient Care
    • 12.8.5.4 Segmentation By End Use
      • 12.8.5.4.1 Payers
      • 12.8.5.4.2 Healthcare Providers
      • 12.8.5.4.3 Healthcare Manufacturers
  • 12.8.6 Italy
    • 12.8.6.1 Segmentation By Component
      • 12.8.6.1.1 Software
      • 12.8.6.1.2 Services
    • 12.8.6.2 Segmentation By Mode of Delivery
      • 12.8.6.2.1 Cloud-based
      • 12.8.6.2.2 On-premise
      • 12.8.6.2.3 Hybrid
    • 12.8.6.3 Segmentation By Application
      • 12.8.6.3.1 Financial Analysis
      • 12.8.6.3.2 Clinical Analysis
      • 12.8.6.3.3 Operational Analysis
      • 12.8.6.3.4 Patient Care
    • 12.8.6.4 Segmentation By End Use
      • 12.8.6.4.1 Payers
      • 12.8.6.4.2 Healthcare Providers
      • 12.8.6.4.3 Healthcare Manufacturers
  • 12.8.7 Rest of Europe
    • 12.8.7.1 Segmentation By Component
      • 12.8.7.1.1 Software
      • 12.8.7.1.2 Services
    • 12.8.7.2 Segmentation By Mode of Delivery
      • 12.8.7.2.1 Cloud-based
      • 12.8.7.2.2 On-premise
      • 12.8.7.2.3 Hybrid
    • 12.8.7.3 Segmentation By Application
      • 12.8.7.3.1 Financial Analysis
      • 12.8.7.3.2 Clinical Analysis
      • 12.8.7.3.3 Operational Analysis
      • 12.8.7.3.4 Patient Care
    • 12.8.7.4 Segmentation By End Use
      • 12.8.7.4.1 Payers
      • 12.8.7.4.2 Healthcare Providers
      • 12.8.7.4.3 Healthcare Manufacturers

Chapter 13. Asia Pacific Market

• 13.1 Market Overview
• 13.2 Key Factors Impacting Market
  • 13.2.1 Market Drivers
  • 13.2.2 Market Restraints
  • 13.2.3 Market Opportunities
  • 13.2.4 Market Challenges
  • 13.2.5 Market Trends
  • 13.2.6 State of Competition
  • 13.2.7 Market Consolidation
  • 13.2.8 Key Customer Criteria
• 13.3 Product Life Cycle
• 13.4 Segmentation By Component
  • 13.4.1 Software
  • 13.4.2 Services
• 13.5 Segmentation By Mode of Delivery
  • 13.5.1 Cloud-based
  • 13.5.2 On-premise
  • 13.5.3 Hybrid
• 13.6 Segmentation By Application
  • 13.6.1 Financial Analysis
  • 13.6.2 Clinical Analysis
  • 13.6.3 Operational Analysis
  • 13.6.4 Patient Care
• 13.7 Segmentation By End Use
  • 13.7.1 Payers
  • 13.7.2 Healthcare Providers
  • 13.7.3 Healthcare Manufacturers
• 13.8 Segmentation By Country
  • 13.8.1 China
    • 13.8.1.1 Segmentation By Component
      • 13.8.1.1.1 Software
      • 13.8.1.1.2 Services
    • 13.8.1.2 Segmentation By Mode of Delivery
      • 13.8.1.2.1 Cloud-based
      • 13.8.1.2.2 On-premise
      • 13.8.1.2.3 Hybrid
    • 13.8.1.3 Segmentation By Application
      • 13.8.1.3.1 Financial Analysis
      • 13.8.1.3.2 Clinical Analysis
      • 13.8.1.3.3 Operational Analysis
      • 13.8.1.3.4 Patient Care
    • 13.8.1.4 Segmentation By End Use
      • 13.8.1.4.1 Payers
      • 13.8.1.4.2 Healthcare Providers
      • 13.8.1.4.3 Healthcare Manufacturers
  • 13.8.2 Japan
    • 13.8.2.1 Segmentation By Component
      • 13.8.2.1.1 Software
      • 13.8.2.1.2 Services
    • 13.8.2.2 Segmentation By Mode of Delivery
      • 13.8.2.2.1 Cloud-based
      • 13.8.2.2.2 On-premise
      • 13.8.2.2.3 Hybrid
    • 13.8.2.3 Segmentation By Application
      • 13.8.2.3.1 Financial Analysis
      • 13.8.2.3.2 Clinical Analysis
      • 13.8.2.3.3 Operational Analysis
      • 13.8.2.3.4 Patient Care
    • 13.8.2.4 Segmentation By End Use
      • 13.8.2.4.1 Payers
      • 13.8.2.4.2 Healthcare Providers
      • 13.8.2.4.3 Healthcare Manufacturers
  • 13.8.3 India
    • 13.8.3.1 Segmentation By Component
      • 13.8.3.1.1 Software
      • 13.8.3.1.2 Services
    • 13.8.3.2 Segmentation By Mode of Delivery
      • 13.8.3.2.1 Cloud-based
      • 13.8.3.2.2 On-premise
      • 13.8.3.2.3 Hybrid
    • 13.8.3.3 Segmentation By Application
      • 13.8.3.3.1 Financial Analysis
      • 13.8.3.3.2 Clinical Analysis
      • 13.8.3.3.3 Operational Analysis
      • 13.8.3.3.4 Patient Care
    • 13.8.3.4 Segmentation By End Use
      • 13.8.3.4.1 Payers
      • 13.8.3.4.2 Healthcare Providers
      • 13.8.3.4.3 Healthcare Manufacturers
  • 13.8.4 South Korea
    • 13.8.4.1 Segmentation By Component
      • 13.8.4.1.1 Software
      • 13.8.4.1.2 Services
    • 13.8.4.2 Segmentation By Mode of Delivery
      • 13.8.4.2.1 Cloud-based
      • 13.8.4.2.2 On-premise
      • 13.8.4.2.3 Hybrid
    • 13.8.4.3 Segmentation By Application
      • 13.8.4.3.1 Financial Analysis
      • 13.8.4.3.2 Clinical Analysis
      • 13.8.4.3.3 Operational Analysis
      • 13.8.4.3.4 Patient Care
    • 13.8.4.4 Segmentation By End Use
      • 13.8.4.4.1 Payers
      • 13.8.4.4.2 Healthcare Providers
      • 13.8.4.4.3 Healthcare Manufacturers
  • 13.8.5 Singapore
    • 13.8.5.1 Segmentation By Component
      • 13.8.5.1.1 Software
      • 13.8.5.1.2 Services
    • 13.8.5.2 Segmentation By Mode of Delivery
      • 13.8.5.2.1 Cloud-based
      • 13.8.5.2.2 On-premise
      • 13.8.5.2.3 Hybrid
    • 13.8.5.3 Segmentation By Application
      • 13.8.5.3.1 Financial Analysis
      • 13.8.5.3.2 Clinical Analysis
      • 13.8.5.3.3 Operational Analysis
      • 13.8.5.3.4 Patient Care
    • 13.8.5.4 Segmentation By End Use
      • 13.8.5.4.1 Payers
      • 13.8.5.4.2 Healthcare Providers
      • 13.8.5.4.3 Healthcare Manufacturers
  • 13.8.6 Malaysia
    • 13.8.6.1 Segmentation By Component
      • 13.8.6.1.1 Software
      • 13.8.6.1.2 Services
    • 13.8.6.2 Segmentation By Mode of Delivery
      • 13.8.6.2.1 Cloud-based
      • 13.8.6.2.2 On-premise
      • 13.8.6.2.3 Hybrid
    • 13.8.6.3 Segmentation By Application
      • 13.8.6.3.1 Financial Analysis
      • 13.8.6.3.2 Clinical Analysis
      • 13.8.6.3.3 Operational Analysis
      • 13.8.6.3.4 Patient Care
    • 13.8.6.4 Segmentation By End Use
      • 13.8.6.4.1 Payers
      • 13.8.6.4.2 Healthcare Providers
      • 13.8.6.4.3 Healthcare Manufacturers
  • 13.8.7 Rest of Asia Pacific
    • 13.8.7.1 Segmentation By Component
      • 13.8.7.1.1 Software
      • 13.8.7.1.2 Services
    • 13.8.7.2 Segmentation By Mode of Delivery
      • 13.8.7.2.1 Cloud-based
      • 13.8.7.2.2 On-premise
      • 13.8.7.2.3 Hybrid
    • 13.8.7.3 Segmentation By Application
      • 13.8.7.3.1 Financial Analysis
      • 13.8.7.3.2 Clinical Analysis
      • 13.8.7.3.3 Operational Analysis
      • 13.8.7.3.4 Patient Care
    • 13.8.7.4 Segmentation By End Use
      • 13.8.7.4.1 Payers
      • 13.8.7.4.2 Healthcare Providers
      • 13.8.7.4.3 Healthcare Manufacturers

Chapter 14. LAMEA Market

• 14.1 Market Overview
• 14.2 Key Factors Impacting Market
  • 14.2.1 Market Drivers
  • 14.2.2 Market Restraints
  • 14.2.3 Market Opportunities
  • 14.2.4 Market Challenges
  • 14.2.5 Market Trends
  • 14.2.6 State of Competition
  • 14.2.7 Market Consolidation
  • 14.2.8 Key Customer Criteria
• 14.3 Product Life Cycle
• 14.4 Segmentation By Component
  • 14.4.1 Software
  • 14.4.2 Services
• 14.5 Segmentation By Mode of Delivery
  • 14.5.1 Cloud-based
  • 14.5.2 On-premise
  • 14.5.3 Hybrid
• 14.6 Segmentation By Application
  • 14.6.1 Financial Analysis
  • 14.6.2 Clinical Analysis
  • 14.6.3 Operational Analysis
  • 14.6.4 Patient Care
• 14.7 Segmentation By End Use
  • 14.7.1 Payers
  • 14.7.2 Healthcare Providers
  • 14.7.3 Healthcare Manufacturers
• 14.8 Segmentation By Country
  • 14.8.1 Brazil
    • 14.8.1.1 Segmentation By Component
      • 14.8.1.1.1 Software
      • 14.8.1.1.2 Services
    • 14.8.1.2 Segmentation By Mode of Delivery
      • 14.8.1.2.1 Cloud-based
      • 14.8.1.2.2 On-premise
      • 14.8.1.2.3 Hybrid
    • 14.8.1.3 Segmentation By Application
      • 14.8.1.3.1 Financial Analysis
      • 14.8.1.3.2 Clinical Analysis
      • 14.8.1.3.3 Operational Analysis
      • 14.8.1.3.4 Patient Care
    • 14.8.1.4 Segmentation By End Use
      • 14.8.1.4.1 Payers
      • 14.8.1.4.2 Healthcare Providers
      • 14.8.1.4.3 Healthcare Manufacturers
  • 14.8.2 Argentina
    • 14.8.2.1 Segmentation By Component
      • 14.8.2.1.1 Software
      • 14.8.2.1.2 Services
    • 14.8.2.2 Segmentation By Mode of Delivery
      • 14.8.2.2.1 Cloud-based
      • 14.8.2.2.2 On-premise
      • 14.8.2.2.3 Hybrid
    • 14.8.2.3 Segmentation By Application
      • 14.8.2.3.1 Financial Analysis
      • 14.8.2.3.2 Clinical Analysis
      • 14.8.2.3.3 Operational Analysis
      • 14.8.2.3.4 Patient Care
    • 14.8.2.4 Segmentation By End Use
      • 14.8.2.4.1 Payers
      • 14.8.2.4.2 Healthcare Providers
      • 14.8.2.4.3 Healthcare Manufacturers
  • 14.8.3 UAE
    • 14.8.3.1 Segmentation By Component
      • 14.8.3.1.1 Software
      • 14.8.3.1.2 Services
    • 14.8.3.2 Segmentation By Mode of Delivery
      • 14.8.3.2.1 Cloud-based
      • 14.8.3.2.2 On-premise
      • 14.8.3.2.3 Hybrid
    • 14.8.3.3 Segmentation By Application
      • 14.8.3.3.1 Financial Analysis
      • 14.8.3.3.2 Clinical Analysis
      • 14.8.3.3.3 Operational Analysis
      • 14.8.3.3.4 Patient Care
    • 14.8.3.4 Segmentation By End Use
      • 14.8.3.4.1 Payers
      • 14.8.3.4.2 Healthcare Providers
      • 14.8.3.4.3 Healthcare Manufacturers
  • 14.8.4 Saudi Arabia
    • 14.8.4.1 Segmentation By Component
      • 14.8.4.1.1 Software
      • 14.8.4.1.2 Services
    • 14.8.4.2 Segmentation By Mode of Delivery
      • 14.8.4.2.1 Cloud-based
      • 14.8.4.2.2 On-premise
      • 14.8.4.2.3 Hybrid
    • 14.8.4.3 Segmentation By Application
      • 14.8.4.3.1 Financial Analysis
      • 14.8.4.3.2 Clinical Analysis
      • 14.8.4.3.3 Operational Analysis
      • 14.8.4.3.4 Patient Care
    • 14.8.4.4 Segmentation By End Use
      • 14.8.4.4.1 Payers
      • 14.8.4.4.2 Healthcare Providers
      • 14.8.4.4.3 Healthcare Manufacturers
  • 14.8.5 South Africa
    • 14.8.5.1 Segmentation By Component
      • 14.8.5.1.1 Software
      • 14.8.5.1.2 Services
    • 14.8.5.2 Segmentation By Mode of Delivery
      • 14.8.5.2.1 Cloud-based
      • 14.8.5.2.2 On-premise
      • 14.8.5.2.3 Hybrid
    • 14.8.5.3 Segmentation By Application
      • 14.8.5.3.1 Financial Analysis
      • 14.8.5.3.2 Clinical Analysis
      • 14.8.5.3.3 Operational Analysis
      • 14.8.5.3.4 Patient Care
    • 14.8.5.4 Segmentation By End Use
      • 14.8.5.4.1 Payers
      • 14.8.5.4.2 Healthcare Providers
      • 14.8.5.4.3 Healthcare Manufacturers
  • 14.8.6 Nigeria
    • 14.8.6.1 Segmentation By Component
      • 14.8.6.1.1 Software
      • 14.8.6.1.2 Services
    • 14.8.6.2 Segmentation By Mode of Delivery
      • 14.8.6.2.1 Cloud-based
      • 14.8.6.2.2 On-premise
      • 14.8.6.2.3 Hybrid
    • 14.8.6.3 Segmentation By Application
      • 14.8.6.3.1 Financial Analysis
      • 14.8.6.3.2 Clinical Analysis
      • 14.8.6.3.3 Operational Analysis
      • 14.8.6.3.4 Patient Care
    • 14.8.6.4 Segmentation By End Use
      • 14.8.6.4.1 Payers
      • 14.8.6.4.2 Healthcare Providers
      • 14.8.6.4.3 Healthcare Manufacturers
  • 14.8.7 Rest of LAMEA
    • 14.8.7.1 Segmentation By Component
      • 14.8.7.1.1 Software
      • 14.8.7.1.2 Services
    • 14.8.7.2 Segmentation By Mode of Delivery
      • 14.8.7.2.1 Cloud-based
      • 14.8.7.2.2 On-premise
      • 14.8.7.2.3 Hybrid
    • 14.8.7.3 Segmentation By Application
      • 14.8.7.3.1 Financial Analysis
      • 14.8.7.3.2 Clinical Analysis
      • 14.8.7.3.3 Operational Analysis
      • 14.8.7.3.4 Patient Care
    • 14.8.7.4 Segmentation By End Use
      • 14.8.7.4.1 Payers
      • 14.8.7.4.2 Healthcare Providers
      • 14.8.7.4.3 Healthcare Manufacturers

Chapter 15. Company Snapshots

• 15.1 Microsoft Corporation
  • 15.1.1 Business Overview
  • 15.1.2 Key Information
  • 15.1.3 Company Focus on Healthcare Business Intelligence Market
  • 15.1.4 Strategic Insights
  • 15.1.5 Strategy Deployed
  • 15.1.6 Product & Service Portfolio
  • 15.1.7 Representative Products
  • 15.1.8 Capability Overview
  • 15.1.9 Technology & Innovation Focus
  • 15.1.10 SWOT Analysis
  • 15.1.11 Customers / End Users
  • 15.1.12 Competitive Positioning
  • 15.1.13 Key Differentiators
  • 15.1.14 Portfolio Matrix
  • 15.1.15 Analyst View
  • 15.1.16 Future Outlook
• 15.2 Oracle Corporation
  • 15.2.1 Business Overview
  • 15.2.2 Key Information
  • 15.2.3 Company Focus on Healthcare Business Intelligence Market
  • 15.2.4 Strategic Insights
  • 15.2.5 Strategy Deployed Integration of reporting and analytics within Oracle Health clinical applications.
  • 15.2.6 Product & Service Portfolio
  • 15.2.7 Representative Products
  • 15.2.8 Capability Overview
  • 15.2.9 Technology & Innovation Focus
  • 15.2.10 SWOT Analysis
  • 15.2.11 Customers / End Users
  • 15.2.12 Competitive Positioning
  • 15.2.13 Key Differentiators
  • 15.2.14 Portfolio Matrix
  • 15.2.15 Analyst View
  • 15.2.16 Future Outlook
• 15.3 Salesforce, Inc.
  • 15.3.1 Business Overview
  • 15.3.2 Key Information
  • 15.3.3 Company Focus on Healthcare Business Intelligence Market
  • 15.3.4 Strategic Insights
  • 15.3.5 Strategy Deployed
  • 15.3.6 Product & Service Portfolio
  • 15.3.7 Representative Products
  • 15.3.8 Capability Overview
  • 15.3.9 Technology & Innovation Focus
  • 15.3.10 SWOT Analysis
  • 15.3.11 Customers / End Users
  • 15.3.12 Competitive Positioning
  • 15.3.13 Key Differentiators
  • 15.3.14 Portfolio Matrix
  • 15.3.15 Analyst View
  • 15.3.16 Future Outlook
• 15.4 Health Catalyst, Inc.
  • 15.4.1 Business Overview
  • 15.4.2 Key Information
  • 15.4.3 Company Focus on Healthcare Business Intelligence Market
  • 15.4.4 Strategic Insights
  • 15.4.5 Strategy Deployed
  • 15.4.6 Product & Service Portfolio
  • 15.4.7 Representative Products
  • 15.4.8 Capability Overview
  • 15.4.9 Technology & Innovation Focus
  • 15.4.10 SWOT Analysis
  • 15.4.11 Customers / End Users
  • 15.4.12 Competitive Positioning
  • 15.4.13 Key Differentiators
  • 15.4.14 Portfolio Matrix
  • 15.4.15 Analyst View
  • 15.4.16 Future Outlook
• 15.5 QlikTech International AB (Qlik)
  • 15.5.1 Business Overview
  • 15.5.2 Key Information
  • 15.5.3 Company Focus on Healthcare Business Intelligence Market
  • 15.5.4 Strategic Insights on Healthcare Business Intelligence Market
  • 15.5.5 Strategy Deployed
  • 15.5.6 Product & Service Portfolio
  • 15.5.7 Representative Products
  • 15.5.8 Capability Overview
  • 15.5.9 Technology & Innovation Focus
  • 15.5.10 SWOT Analysis
  • 15.5.11 Customers / End Users
  • 15.5.12 Competitive Positioning
  • 15.5.13 Key Differentiators
  • 15.5.14 Portfolio Matrix
  • 15.5.15 Analyst View
  • 15.5.16 Future Outlook
• 15.6 Innovaccer Inc.
  • 15.6.1 Business Overview
  • 15.6.2 Key Information
  • 15.6.3 Company Focus on Healthcare Business Intelligence Market
  • 15.6.4 Strategic Insights
  • 15.6.5 Strategy Deployed
  • 15.6.6 Product & Service Portfolio
  • 15.6.7 Representative Products
  • 15.6.8 Capability Overview
  • 15.6.9 Technology & Innovation Focus
  • 15.6.10 SWOT Analysis
  • 15.6.11 Customers / End Users
  • 15.6.12 Competitive Positioning
  • 15.6.13 Key Differentiators
  • 15.6.14 Portfolio Matrix
  • 15.6.15 Analyst View
  • 15.6.16 Future Outlook
• 15.7 SAP SE
  • 15.7.1 Business Overview
  • 15.7.2 Key Information
  • 15.7.3 Company Focus on Healthcare Business Intelligence Market
  • 15.7.4 Strategic Insights
  • 15.7.5 Strategy Deployed
  • 15.7.6 Product & Service Portfolio
  • 15.7.7 Representative Products
  • 15.7.8 Capability Overview
  • 15.7.9 Technology & Innovation Focus
  • 15.7.10 SWOT Analysis
  • 15.7.11 Customers / End Users
  • 15.7.12 Competitive Positioning
  • 15.7.13 Key Differentiators
  • 15.7.14 Portfolio Matrix
  • 15.7.15 Analyst View
  • 15.7.16 Future Outlook
• 15.8 SAS Institute Inc.
  • 15.8.1 Business Overview
  • 15.8.2 Key Information
  • 15.8.3 Company Focus on Healthcare Business Intelligence Market
  • 15.8.4 Strategic Insights
  • 15.8.5 Strategy Deployed
  • 15.8.6 Product & Service Portfolio
  • 15.8.7 Representative Products
  • 15.8.8 Capability Overview
  • 15.8.9 Technology & Innovation Focus
  • 15.8.10 SWOT Analysis
  • 15.8.11 Customers / End Users
  • 15.8.12 Competitive Positioning
  • 15.8.13 Key Differentiators
  • 15.8.14 Portfolio Matrix
  • 15.8.15 Analyst View
  • 15.8.16 Future Outlook
• 15.9 Infor, Inc.
  • 15.9.1 Business Overview
  • 15.9.2 Key Information
  • 15.9.3 Company Focus on Healthcare Business Intelligence Market
  • 15.9.4 Strategic Insights
  • 15.9.5 Strategy Deployed
  • 15.9.6 Product & Service Portfolio
  • 15.9.7 Representative Products
  • 15.9.8 Capability Overview
  • 15.9.9 Technology & Innovation Focus
  • 15.9.10 SWOT Analysis
  • 15.9.11 Customers / End Users
  • 15.9.12 Competitive Positioning
  • 15.9.13 Key Differentiators
  • 15.9.14 Portfolio Matrix
  • 15.9.15 Analyst View
  • 15.9.16 Future Outlook
• 15.10 Epic Systems Corporation
  • 15.10.1 Business Overview
  • 15.10.2 Key Information
  • 15.10.3 Company Focus on Healthcare Business Intelligence Market
  • 15.10.4 Strategic Insights
  • 15.10.5 Strategy Deployed
  • 15.10.6 Product & Service Portfolio
  • 15.10.7 Representative Products
  • 15.10.8 Capability Overview
  • 15.10.9 Technology & Innovation Focus
  • 15.10.10 SWOT Analysis
  • 15.10.11 Customers / End Users
  • 15.10.12 Competitive Positioning
  • 15.10.13 Key Differentiators
  • 15.10.14 Portfolio Matrix
  • 15.10.15 Analyst View
  • 15.10.16 Future Outlook

Chapter 16. Winning Imperatives of Healthcare Business Intelligence Market